Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome)

Citation
Am. Carrozzo et al., Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome), J EUR A D V, 14(2), 2000, pp. 131-133
Citations number
22
Categorie Soggetti
Dermatology
Journal title
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
ISSN journal
09269959 → ACNP
Volume
14
Issue
2
Year of publication
2000
Pages
131 - 133
Database
ISI
SICI code
0926-9959(200003)14:2<131:CTOCAR>2.0.ZU;2-A
Abstract
Gougerot-Carteaud syndrome or confluent and reticulated papillomatosis (CRP ), was first described by Gougerot and Carteaud as dermatosis.(1,2) It is g enerally considered a rare condition. The eruption consists confluent, flat , brown papules localized primarily to the intermammary and interscapular r egions with subsequent spread to the breast and abdomen; at the periphery, the papules spread out forming a pigmented reticulated pattern. At present, the aetiology of CRP remains unknown. The two prominent theories are an ab normal host response to fungi(3) and a keratinization defect.(4,5) Other hy pothesis include photosensitivity,(6) genetic factor,(7) amylodosis cutis(8 ) and endocrinopathy.(9)